Research and Markets: Acne & Rosacea Therapeutics: Ten Emerging Acne and Rosacea Therapies in Phase and Clinical Development Expected to launch by 2009.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com) has announced the addition of Acne & Rosacea Rosacea Definition Rosacea is a skin disease typically appearing in people during their 30s and 40s. It is marked by redness (erythema) of the face, flushing of the skin, and the presence of hard pimples (papules) or pus-filled pimples (pustules), and Therapeutics to their offering. With 85% of people worldwide suffering from acne at some point in their lives, leading to more than 103 million affected by acne and another 45 million by rosacea, the global market for prescription dermatological therapeutics continues to be substantial. Current drugs include a variety of topical and systemic medications such as antibiotics, ant infectives, ant inflammatory, hormone therapies, keratolytics, and retinoids--many of which are indicated for both diseases. The worldwide acne and rosacea therapeutics market is estimated at over $2.16B in 2004 and is expected to grow at a compound annual rate of 1.4% to reach more than $2.31B worldwide by 2009.Although market growth is stabilizing, there is still a pressing demand for new products since most current therapies are associated with adverse side effects Side effects Effects of a proposed project on other parts of the firm. including skin irritation skin irritation, n reaction to a particular irritant that results in inflammation of the skin and itchiness. , depression, and birth defects birth defects, abnormalities in physical or mental structure or function that are present at birth. They range from minor to seriously deforming or life-threatening. A major defect of some type occurs in approximately 3% of all births. . This report includes an in-depth evaluation of physician perspectives and a competitive benchmarking analysis of all acne and rosacea therapeutics expected to reach the market by the end of 2009. In addition, the study provides industry-wide revenue forecasts, including market share segmentation by company and by drug class. Although many treatment options are available, even the most commonly prescribed topical therapeutics, like Adapalene for acne and Metronidazole metronidazole /met·ro·ni·da·zole/ (-ni´dah-zol) an antiprotozoal and antibacterial effective against obligate anaerobes; used as the base or the hydrochloride salt. It is also used as a topical treatment for rosacea. for rosacea, result in adverse side effects like skin irritations, driving the need for improved treatments with higher efficacy levels and better safety profiles. With the time to market often shorter for dermatological products than for other therapeutic classes, ten emerging acne and rosacea therapies in phase and clinical development are expected to launch by 2009. Although the market is crowded by competition from generics and OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). preparations, new drug candidates including hormone therapies, ant infectives, antibiotics, retinoids Retinoids A derivative of synthetic Vitamin A. Mentioned in: Ichthyosis retinoids (reˑ·t , and combination products will provide opportunities for smaller pharmaceuticals companies like Atrix, Cipher cipher: see cryptography. (1) The core algorithm used to encrypt data. A cipher transforms regular data (plaintext) into a coded set of data (ciphertext) that is not reversible without a key. , and Connectics to gain market share from dominant players like Sanof Aventis, Galderma, and Roche. For a comprehensive analysis of this market, the report: - Provides a detailed scientific background of both acne and rosacea, including unmet treatment needs - Evaluates leading current and emerging therapeutics on issues such as efficacy, safety, and ease of use - Assesses data from 30 physician interviews, with discussion of treatment protocols and trends, prescription preferences, and disease progression patterns - Provides worldwide market forecast and revenue models from 2004 through 2009 with detailed assumptions for each current and emerging therapeutic as well as the industry as a whole -Analyzes the strategic positioning of 10 emerging acne and rosacea therapeutics Companies Mentioned: Bradley Pharmaceuticals Bradley Pharmaceuticals is a pharmaceutical company headquartered in Fairfield Township, Essex County, New Jersey. The company was founded in 1985 by Daniel Glassman who is at the current time its CEO. The company markets to niche physician specialties in the U.S. Inc. Connetics Corporation Fujisawa Healthcare, Inc. Otsuka America Pharmaceutical, Inc Mylan Laboratories Inc. Sirius Ranbaxy Laboratories Ranbaxy Laboratories Limited is an Indian company incorporated in 1961. It is India's largest pharmaceutical company. It exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries. Ltd Wyeth Report Contents: I. Executive Summary II. Objectives and Methodology III. Clinical Overview IV. Current Treatments and Physician Insights V. Emerging Therapeutics VI. Acne and Rosacea Market For more information visit http://www.researchandmarkets.com/reports/c5314 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion